Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma

被引：0
|
作者：
Pavord, I. [1 ]
Pandit-Abid, N. [2 ]
Israel, E. [3 ,4 ]
Szefler, S. [5 ]
Brusselle, G. [6 ]
Rabe, K. [7 ,8 ]
Chen, Z. [9 ]
Altincatal, A. [10 ]
Amin, N. [9 ]
Khan, A. [11 ]
Lederer, D. H. [9 ]
Zhang, Y. [9 ]
Rowe, P. J. [2 ]
Deniz, Y. [9 ]
Amr, R. [9 ]
Jacob-Nara, J. A. [2 ]
Busse, W. W. [12 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Sanofi, Bridgewater, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
[6] Ghent Univ Hosp, Ghent, Belgium
[7] LungenClin Grosshansdorf, Grosshansdorf, Germany
[8] Univ Kiel, Kiel, Germany
[9] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[10] Sanofi, Cambridge, MA USA
[11] Sanofi, Chilly Mazarin, France
[12] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000327
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [1] Dupilumab Induces Clinical Remission in Patients With Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
    Pavord, I. D.
    Israel, E.
    Szefler, S. J.
    Brusselle, G.
    Rabe, K. F.
    Chen, Z.
    Altincatal, A.
    Radwan, A.
    Pandit-Abid, N.
    Amin, N.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y. M.
    Khan, A.
    Lederer, D. J.
    Zhang, Y.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
    Pavord, Ian
    Busse, William
    Israel, Elliot
    Szefler, Stanley
    Chen, Zhen
    Daizadeh, Nadia
    Lederer, David
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    Khan, Asif
    Zhang, Yi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB4 - AB4
  • [3] Late Breaking Abstract- Clinical remission with dupilumab in children with uncontrolled, moderate-to-severe, type 2 asthma
    Bacharier, Leonard
    Guilbert, Theresa W.
    Maspero, Jorge F.
    Gappa, Monika
    Dell, Sharon
    Altincatal, Arman
    Ledanois, Olivier
    Gall, Rebecca
    Sacks, Harry
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [5] Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Jain, Neal
    Sher, Lawrence D.
    Mao, X.
    Liu, D.
    Zhang, Yi
    Khan, Asif H.
    Kapoor, Upender
    Khokhar, Faisal A.
    Rowe, Paul J.
    Deniz, Yamo
    Ruddy, Marcella
    Laws, Elizabeth
    Patel, Naimish
    Weinreich, David M.
    Yancopoulos, George D.
    Amin, Nikhil
    Mannent, Leda P.
    Lederer, David J.
    Hardin, Megan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2230 - 2240
  • [6] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
    Miller, Mechelle A.
    Davis, Karla L.
    PEDIATRICS, 2020, 146 : S375 - S375
  • [7] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [8] Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to-severe type 2 inflammatory asthma by allergen sensitization status
    Phipatanakul, W.
    Papadopoulos, N. G.
    Hernandez-Trujillo, V.
    Hamelmann, E.
    Zeiger, R. S.
    Ducharme, F. M.
    Jain, N.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 604 - 604
  • [9] Is Dupilumab Effective in Treating Uncontrolled Moderate-to-Severe Asthma?
    Lo, Rachelle
    McGhee, Sean
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (05): : 1705 - 1706
  • [10] Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J.
    Wenzel, S.
    Rabe, K. F.
    Busse, W. W.
    Ford, L.
    Sher, L.
    FitzGerald, J. M.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M. H.
    Hamilton, J. D.
    Swanson, B. N.
    Stahl, N.
    Yancopoulos, G. D.
    Teper, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2486 - 2496
12345